Skip to main content
SpringerLink
Log in

Rational Antithrombotic Therapy and Prophylaxis in Elderly, Immobile Patients

  • Review Article
  • Drug Therapy
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

The aging process is associated with increased coagulation and fibrinolysis parameters, resulting in an overall ‘prethrombotic state’. This probably explains the increased baseline susceptibility of elderly patients to the development of thromboembolic disease. Additional factors such as major surgery or malignant disease multiply the risk of thromboembolism in this population.

Even when adequate antithrombotic therapy is instituted, the mortality associated with thromboembolic disease remains considerable; this underlines the importance of adequate thromboembolic prophylaxis. At present, the use of low molecular weight heparins (LMWHs) in elderly immobile patients appears to be the most effective approach to prophylaxis. The use of compression stockings seems to be effective in the prevention of venous thrombosis, at least in moderate risk surgical patients. In patients undergoing orthopaedic surgery, additional prophylaxis (e.g. with an LMWH) is necessary.

In the management of venous thrombosis, patients can initially be treated with a bodyweight-adjusted dosage of an LMWH. In patients with deep vein leg thrombosis or pulmonary embolism, oral anticoagulant therapy should be started as soon as possible, and should be continued for 6 months. However, before starting prophylaxis or therapy, an individual risk assessment should be performed in which the benefits and disadvantages are balanced.

Most of the large trials that have studied the effects of thromboembolic prophylaxis have focused on postsurgical patients. However, it will be of great interest to develop more specific prophylactic and therapeutic regimens for different nonsurgical high risk subgroups of patients, particularly the elderly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hirsh J. Pulmonary embolism in the elderly. Cardiol Clin 1991; 9: 457–74

    PubMed  CAS  Google Scholar 

  2. Matzdorff AC, Green D. Deep vein thrombosis and pulmonary embolism: prevention, diagnosis and treatment. Geriatrics 1992; 47: 48–63

    PubMed  CAS  Google Scholar 

  3. Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med 1989; 82: 203–5

    PubMed  CAS  Google Scholar 

  4. Thromboembolic Risk Factors (THRIFT) Consensus Group. Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ 1992; 305: 567–74

    Article  Google Scholar 

  5. Kniffin WD, Baron JA, Barrett J, et al. The epidemiology of diagnosed pulmonary embolism and deep vein thrombosis in the elderly. Arch Intern Med 1994; 154: 861–6

    Article  PubMed  Google Scholar 

  6. Sevitt S, Gallagher NG. Venous thrombosis and pulmonary embolism: a clinico-pathological study in injured and burned patients. Br J Surg 1961; 48: 475–89

    Article  PubMed  CAS  Google Scholar 

  7. Kinasewitz GT. Thrombophlebitis and pulmonary embolism in the elderly patient. Clin Chest Med 1993; 14: 523–36

    PubMed  CAS  Google Scholar 

  8. Nurmohamed MT, Büller HR, ten Cate JW. Physiological changes due to age: implications for the prevention and treatment of thrombosis in older patients. Drugs Aging 1994; 5 (1): 20–33

    Article  PubMed  CAS  Google Scholar 

  9. Mari D, Mannucci R, Coppola R, et al. Hypercoagulability in centenarians: the paradox of successful ageing. Blood 1995; 85: 3144–9

    PubMed  CAS  Google Scholar 

  10. Schina MJ, Neumyer MM, Healy DA, et al. Influence of age on venous physiologic parameters. J Vasc Surg 1993; 18: 749–52

    Article  PubMed  Google Scholar 

  11. National Institutes of Health Consensus Conference. Prevention of venous thrombosis and pulmonary embolism. JAMA 1986; 256: 744–9

    Article  Google Scholar 

  12. Goldhaber SZ, Morpurgo M. Diagnosis, treatment, and prevention of pulmonary embolism: report of the WHO/International Society and Federation of Cardiology Task Force. JAMA 1992; 268: 1727–33

    Article  PubMed  CAS  Google Scholar 

  13. Planes A, Vochelle N, Darmon JY, et al. Risk of deep venous thrombosis after hospital discharge in patients having undergone total hip replacement: double blind randomised comparison of enoxaparin versus placebo. Lancet 1996; 348: 224–8

    Article  PubMed  CAS  Google Scholar 

  14. Bergqvist D. New approaches to prevention of deep vein thrombosis. Thromb Haemost 1997; 78: 684–8

    PubMed  CAS  Google Scholar 

  15. Cohen AT, Edmondson RA, Philips MJ, et al. The changing pattern of venous thromboembolic disease. Haemostasis 1996; 26: 65–71

    PubMed  CAS  Google Scholar 

  16. Davie EW, Fujikawa K, Kisiel W. The coagulation cascade: initiation, maintenance and regulation. Biochemistry 1991; 30: 10363–70

    Article  PubMed  CAS  Google Scholar 

  17. Van Gorp ECM, ten Cate H. Coagulation monitoring. In: Webb A, Shapiro MJ, Singer M, et al., editors. Oxford textbook of intensive care medicine. Oxford: Oxford University Press. In press

  18. Tracy R, Bovill E, Fried L, et al. The distribution of coagulation factors VII, VIII and fibrinogen in adults over the age of 65 years: results from the Cardiovascular Health Study. Ann Epidemiol 1992; 2: 509–19

    Article  PubMed  CAS  Google Scholar 

  19. Balleisin L, Bailey J, Epping PH, et al. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill using and menopause. Thromb Haemost 1985; 54: 475–9

    Google Scholar 

  20. Bauer KA, Weiss LM, Sparrow D, et al. Aging associated changes in indices of thrombin generation and protein C activation in humans: normative aging studies. J Clin Invest 1987; 80: 1527–34

    Article  PubMed  CAS  Google Scholar 

  21. Kario K, Matsuo T, Kobayashi H. Which factors effect high D dimer levels in the elderly? Thromb Res 1991; 62: 501–8

    Article  PubMed  CAS  Google Scholar 

  22. Cadroy Y, Pierrejean D, Fontan B, et al. Influence of aging on the activity of the hemostatic system: prothrombin fragment 1+2, thrombin-antithrombin III complexes and D dimers in 80 healthy subjects with age ranging from 20 to 94 years. Nouv Rev Fr Hematol 1992; 34: 43–6

    PubMed  CAS  Google Scholar 

  23. Ranby M, Bergsdorf N, Nilsson T, et al. Age dependence of tissue plasminogen activator concentrations, as studied by an improved enzyme-linked immunosorbent assay. Clin Chem 1986; 32: 2160–5

    PubMed  CAS  Google Scholar 

  24. Robertson BR, Pandolfi M, Nilsson IM. ‘Fibrinolytic activity’ in healthy volunteers at different ages as studied by standardized venous occlusions of arms and legs. Acta Med Scand 1972; 191: 199–202

    PubMed  CAS  Google Scholar 

  25. Barritt DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial. Lancet 1960; I: 1309–12

    Article  Google Scholar 

  26. Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med 1992; 326: 1240–5

    Article  PubMed  CAS  Google Scholar 

  27. Gardlund B, the Heparin Prophylaxis Study Group. Randomised, controlled trial of low dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases. Lancet 1996; 347: 1357–61

    Article  PubMed  CAS  Google Scholar 

  28. Bergmann JF, Neuhart EA. A multicenter randomized double blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. Thromb Haemost 1996; 76: 529–34

    PubMed  CAS  Google Scholar 

  29. Harenberg J, Kallenbach B, Martin U, et al. Randomized controlled study of heparin and low molecular weight heparin for prevention of deep vein thrombosis in medical patients. Thromb Res 1990; 59: 639–50

    Article  PubMed  CAS  Google Scholar 

  30. Clagett GP, Anderson FA, Levine MN, et al. Prevention of venous thromboembolism. Chest 1992; 102 (4 Suppl.): 391S–407S

    Article  PubMed  CAS  Google Scholar 

  31. Prins MH, Gelsema R, Sing AK, et al. Prophylaxis of deep venous thrombosis with a low-molecular-weight heparin (Kabi 2165/Fragmin) in stroke patients. Haemostasis 1989; 19: 245–50

    PubMed  CAS  Google Scholar 

  32. Kakkar VV, Corrigan TP, Fossard DP. Prevention of post operative embolism by low dose heparin: an international multi-centre trial. Lancet 1975; II: 45–51

    Google Scholar 

  33. Collins R, Scrimgeour A, Yusuf S, et al. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. N Engl J Med 1988; 318: 1162–73

    Article  PubMed  CAS  Google Scholar 

  34. Nurmohamed MT, Rosendaal FR, Büller HR, et al. Low molecular weight heparin in general and orthopaedic surgery: a meta-analysis. Lancet 1992; 340: 152–6

    Article  PubMed  CAS  Google Scholar 

  35. Leizorovicz A, Haugh MC, Chapuis FR, et al. Low molecular weight heparin in prevention of perioperative thrombosis. BMJ 1992; 305: 913–20

    Article  PubMed  CAS  Google Scholar 

  36. Kakkar VJ, Cohen AT, Edmonson RA, et al. Low molecular weight heparin for prevention of venous thromboembolism after major abdominal surgery. Lancet 1993; 341: 259–65

    Article  PubMed  CAS  Google Scholar 

  37. Nurmohamed MT, Verhaeghe R, Haas S, et al. Comparative trial of a low molecular weight heparin (enoxaparin) for the prophylaxis of postoperative deep vein thrombosis in general surgery. Am J Surg 1995; 169: 567–71

    Article  PubMed  CAS  Google Scholar 

  38. Bergqvist D, Burmark US, Flordal PA, et al. Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 XaI units in 2070 patients. Br J Surg 1995; 82: 496–501

    Article  PubMed  CAS  Google Scholar 

  39. Nurmohamed MT, Büller HR, ten Cate JW. Prevention of venous thromboembolism in hip fracture patients. In: Marti RK, Dunki Jacobs PB, editors. Hip fractures, state of the art. London: Medical Press Ltd, 1993: 57–69

    Google Scholar 

  40. Morris GK, Mitchell JRA. Warfarin sodium in prevention of deep venous thrombosis and pulmonary embolism in patients with fractured neck of femur. Lancet 1976; II: 869–72

    Article  Google Scholar 

  41. Bergqvist D, Efsing HO, Hallbook T, et al. Thromboembolism after elective and post-traumatic hip surgery: a controlled prophylactic trial with dextran 70 and low dose heparin. Acta Chir Scand 1979; 145: 213–8

    PubMed  CAS  Google Scholar 

  42. Xabregas A, Gray L, Ham JM. Heparin prophylaxis of deep vein thrombosis in patients with a fractured neck of the femur. Med J Aust 1978; 1: 620–2

    PubMed  CAS  Google Scholar 

  43. Lahnborg G. Effect of low dose heparin and dihydroergotamine on frequency of postoperative deep vein thrombosis in patients undergoing posttraumatic hip surgery. Acta Chir Scand 1980; 146: 319–22

    PubMed  CAS  Google Scholar 

  44. Moskovitz PA, Ellenberg SS, Feffer HL, et al. Low dose heparin for prevention of venous thromboembolism in total hip arthroplasty and surgical repair of hip fractures. J Bone Joint Surg Am 1978; 60A: 1065–70

    Google Scholar 

  45. Gallus AS, Hirsh J, Tuttle RJ, et al. Small subcutaneous doses of heparin in prevention of venous thrombosis. N Engl J Med 1973; 288: 545–51

    Article  PubMed  CAS  Google Scholar 

  46. Galasko CSB, Edwards DH, Fearn CB, et al. The value of low dose heparin for the prophylaxis of thromboembolism in patients with transcervical and intertrochanteric femoral fractures. Acta Orthop Scand 1976; 47: 276–82

    Article  PubMed  CAS  Google Scholar 

  47. Korninger C, Schlag G, Poigenfurst J, et al. Randomised trial of low molecular weight heparin (LMWH) versus low dose heparin/acenocoumarin (H/AC) in patients with hip fracture: thromboprophylactic effect and bleeding complications [abstract]. Thromb Haemost 1989; 62: 187

    Google Scholar 

  48. Powers P, Gent M, Klimek M, et al. A randomised double blind trial comparing a low molecular weight heparanoid, Orgaran, with aspirin in the prevention of venous thromboembolism following surgery for hip fracture [abstract]. Thromb Haemost 1993; 69: 1116

    Google Scholar 

  49. Hoffmann R, Kohler A, Platz A, et al. Prevention of deep vein thrombosis (DVT) in hip surgery: low molecular weight heparin (Sandoparin) versus 3x5000 I.U. UF heparin: a randomised prospective study [abstract]. Thromb Haemost 1993; 69: 1055

    Google Scholar 

  50. Bergqvist D, Kettunen K, Fredin H, et al. Thromboprophylaxis in patients with hip fracture: a prospective, randomised, comparative study between ORG 10172 and dextran 70. Surgery 1991; 109: 617–22

    PubMed  CAS  Google Scholar 

  51. Gerhart TN, Yett HS, Robertson LK, et al. Low molecular weight heparinoid compared with warfarin for prophylaxis of deep vein thrombosis in patients who are operated on for fracture of the hip: a prospective randomised trial. J Bone Joint Surg Am 1991; 73A: 494–502

    Google Scholar 

  52. Nurmohamed MT, ten Cate H, ten Cate JW. Low molecular weight heparin(oid)s: clinical investigations and practical recommendations. Drugs 1997; 53 (5): 736–51

    Article  PubMed  CAS  Google Scholar 

  53. Powers PJ, Gent M, Jay RM, et al. A randomised trial of less intensive postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip. Arch Intern Med 1989; 149: 771–4

    Article  PubMed  CAS  Google Scholar 

  54. Borgstrom S, Greitz T, van der Linden W, et al. Anticoagulant prophylaxis of venous thrombosis in patients with fractured neck of the femur. Acta Chir Scand 1965; 129: 500–8

    Google Scholar 

  55. Salzman EW, Davies GC. Prophylaxis of venous thromboembolism. Ann Surg 1980; 191: 207–18

    Article  PubMed  CAS  Google Scholar 

  56. Sabri S, Roberts VC, Cotton LT. Prevention of early post-operative deep vein thrombosis by intermittent compression of the leg during surgery. BMJ 1971; 4: 394–6

    Article  PubMed  CAS  Google Scholar 

  57. Scurr JH, Ibrahim SZ, Faber RG, et al. The efficacy of graduated compression stockings in the prevention of deep vein thrombosis. Br J Surg 1977; 64: 371–3

    Article  PubMed  CAS  Google Scholar 

  58. Skillman JJ, Collins REC, Coe NP, et al. Prevention of deep vein thrombosis in neurosurgical patients: a controlled randomized trial of external pneumatic compression boots. Surgery 1978; 83: 354–8

    PubMed  CAS  Google Scholar 

  59. Clarke-Pearson DL, Synan IS, Hinshaw WM, et al. Prevention of postoperative venous thromboembolism by external pneumatic calf compression in patients with gynecologic malignancy. Obstet Gynecol 1984; 63: 92–8

    PubMed  CAS  Google Scholar 

  60. Rasmussen A, Hansen PT, Lindholt J, et al. Venous thrombosis after abdominal surgery: a comparison between subcutaneous heparin and antithrombotic stockings, or both. J Med 1988; 19 (3&4): 193–201

    PubMed  CAS  Google Scholar 

  61. Turpie AGG, Gallus AS, Beattie WS, et al. Prevention of venous thrombosis in patients with intracranial disease by intermittent pneumatic compression of the calf. Neurology 1977; 27: 435–8

    Article  PubMed  CAS  Google Scholar 

  62. Levine MN, Gent M, Hirsh J, et al. Ardeparin (low molecular weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism: a randomized trial in patients undergoing knee surgery. Arch Intern Med 1996; 156 (8): 851–6

    Article  PubMed  CAS  Google Scholar 

  63. Pineo GF, Hull RD. Prevention and treatment of venous thromboembolism. Drugs 1996; 52 (1): 71–92

    Article  PubMed  CAS  Google Scholar 

  64. Bachmann F, Leyvraz PF. Low molecular weight heparins for prevention of venous thromboembolism following orthopedic surgery. In: Bounameaux H, editor. Low molecular weight heparins in prophylaxis and therapy of thromboembolic diseases. New York: Marcel Dekker Inc., 1994: 187–212

    Google Scholar 

  65. Wells PS, Lensing AWA, Hirsh J. Graduated compressing stockings in the prevention of postoperative venous thromboembolism. Arch Intern Med 1994; 154: 67–72

    Article  PubMed  CAS  Google Scholar 

  66. Imperiale TF, Sperott T. A meta-analysis of methods to prevent venous thromboembolism following total hip replacement [published erratum appears in JAMA 1995; 273: 288]. JAMA 1994; 271: 1780–5

    Article  PubMed  CAS  Google Scholar 

  67. Barker NW, Nygaard KK, Walters W, et al. A statistical study of postoperative venous thrombosis and pulmonary embolism: I. Incidence in various types of operations. Proc Mayo Clin 1940; 15: 769–73

    Google Scholar 

  68. de Takats G, Jesser JH. Pulmonary embolism: suggestions for its diagnosis, prevention and management. JAMA 1940; 114: 1415–21

    Article  Google Scholar 

  69. Short DS. A survey of pulmonary embolism in a general hospital. BMJ 1952; 1: 790–6

    Article  PubMed  CAS  Google Scholar 

  70. Vieweg WVR, Piscaletti RL, Houser JJ, et al. Complications of intravenous heparin administration in elderly women. JAMA 1970; 213: 1303–6

    Article  PubMed  CAS  Google Scholar 

  71. Levine MN, Hirsh J, Kelton JG. Hemorrhagic complications of antithrombotic therapy. In: Colman RW, Hirsch J, Marder VJ, et al., editors. Hemostasis and thrombosis: basic principles and clinical practice. Philadelphia: J.B. Lippincott, 1987: 873–85

    Google Scholar 

  72. Levine MN, Hirsh J, Landefield S, et al. Hemorrhagic complications of anticoagulant treatment. Chest 1992; 102 Suppl.: 352–63

    Google Scholar 

  73. Van der Meer FJM, Rosendaal FR, Vandenbroucke JP, et al. Bleeding complications in oral anticoagulant therapy. Arch Intern Med 1993; 153: 1557–62

    Article  PubMed  Google Scholar 

  74. Campbell NRC, Hull RD, Brant R, et al. Aging and heparin-related bleeding. Arch Intern Med 1996; 156: 857–60

    Article  PubMed  CAS  Google Scholar 

  75. Brandjes DPM, Heyboer H, Büller HR, et al. Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal vein thrombosis. N Engl J Med 1992; 327: 1485–9

    Article  PubMed  CAS  Google Scholar 

  76. Hull RD, Raskob GE, Hirsh J, et al. Continuous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal vein thrombosis. N Engl J Med 1986; 315: 1109–14

    Article  PubMed  CAS  Google Scholar 

  77. Lensing AWA, Prins M, Koopman MMW, et al. Which heparin for proximal deep vein thrombosis? Lancet 1992; 340: 311–2

    Article  PubMed  CAS  Google Scholar 

  78. Leizorovicz A, Simonneau G, Decousus H, et al. Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis. BMJ 1994; 309: 299–304

    Article  PubMed  CAS  Google Scholar 

  79. Lensing AWA, Prins MH, Davidson BL, et al. Treatment of deep venous thrombosis with low molecular weight heparins: a meta-analysis. Arch Intern Med 1995; 155: 601–7

    Article  PubMed  CAS  Google Scholar 

  80. Siragusa S, Cosmi B, Piovella F, et al. Low molecular weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis. Am J Med 1996; 100: 269–77

    Article  PubMed  CAS  Google Scholar 

  81. Weitz JI. Low molecular weight heparins. N Engl J Med 1997; 337: 688–98

    Article  PubMed  CAS  Google Scholar 

  82. Koopman MM, Prandoni P, Piovella F, the Tasman Study Group, et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low molecular weight heparin administered at home. N Engl J Med 1996; 334 (11): 682–7

    Article  PubMed  CAS  Google Scholar 

  83. Levine M, Gent M, Hirsh J, et al. A comparison of low molecular weight heparin administrated primarily at home with un-fractionated heparin administrated in the hospital for proximal deep vein thrombosis. N Engl J Med 1996; 334 (11): 677–81

    Article  PubMed  CAS  Google Scholar 

  84. The Columbus Investigators. Low molecular weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 1997; 337: 657–62

    Article  Google Scholar 

  85. Simonneau G, Sors H, Charbonnier B, et al. A comparison of low molecular weight heparin with unfractionated heparin for acute pulmonary embolism. N Engl J Med 1997; 337: 663–9

    Article  PubMed  CAS  Google Scholar 

  86. Pini M, Aiello S, Manotti C, et al. Low molecular weight heparin versus warfarin in the prevention of recurrences after deep vein thrombosis. Thromb Haemost 1994; 72 (2): 191–7

    PubMed  CAS  Google Scholar 

  87. Monreal M, Lafoz E, Olive A, et al. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (fragmin) in patients with venous thromboembolism and contraindications to coumarin. Thromb Haemost 1994; 71: 7–11

    PubMed  CAS  Google Scholar 

  88. Goldhaber SZ, Vaughan DE, Markis JE, et al. Acute pulmonary embolism treated with tissue plasminogen activator. Lancet 1986; II: 886–9

    Article  Google Scholar 

  89. Goldhaber SZ, Haire WD, Feldstein ML, et al. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right ventricular function and pulmonary perfusion. Lancet 1993; 341: 507–11

    Article  PubMed  CAS  Google Scholar 

  90. Dalla-Volta S, Palla A, Santolicandro AM, et al. Plasminogen Activator Italian Multicenter Study 2 (PAIMS 2): alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. J Am Coll Cardiol 1992; 20: 520–6

    Article  PubMed  CAS  Google Scholar 

  91. Research Committee of the British Thoracic Society. Optimum duration of anticoagulation for deep vein thrombosis and pulmonary embolism. Lancet 1992; 340: 873–6

    Google Scholar 

  92. Levine MN, Hirsh J, Gent M, et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thromb Haemost 1995; 74: 606–11

    PubMed  CAS  Google Scholar 

  93. Schulman S, Rhedin AS, Lindmarker P, et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med 1995; 332: 1661–5

    Article  PubMed  CAS  Google Scholar 

  94. Schulman S, Granqvist S, Holmstrom M, et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. N Engl J Med 1997; 336 (6): 393–8

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Slotervaart Hospital, Amsterdam, The Netherlands

    Eric C. M. van Gorp & Desiderius P. M. Brandjes

  2. Department of Medicine, Division of Vascular Medicine, Academic Medical Centre, Meibergdreef 9, Postbus 22660, 1100 DD, Amsterdam, The Netherlands

    Desiderius P. M. Brandjes &  Jan W. ten Cate

Authors
  1. Eric C. M. van Gorp
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Desiderius P. M. Brandjes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jan W. ten Cate
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

van Gorp, E.C.M., Brandjes, D.P.M. & ten Cate, J.W. Rational Antithrombotic Therapy and Prophylaxis in Elderly, Immobile Patients. Drugs & Aging 13, 145–157 (1998). https://doi.org/10.2165/00002512-199813020-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199813020-00006

Keywords

Search

Navigation